Danaher's quarterly results show signs of life, and the stock in difficulties is triggered
Danaher's actions rose more than 6% on Tuesday after the results of the first quarter of the medical care company…
club profits
We are lowering our target price of Bristol Myers despite a profit rate
Bristol Myers Squibb and Rosy Outlook's profits on Thursday did not solve persistent problems for actions. But it was enough,…
Abbott Labs shares an increase in profits and a great sign of confidence in the business
ABBOTT Laboratories actions jumped on Wednesday after the diversified medical care company delivered strong results of the first quarter and…
Ge Healthcare triggers 9% in Beat profits, wise guide. Here is our new target price
Things continue to seek the actions of Ge Healthcare this year. The actions of the Medical Technology Company increased approximately…
We are reducing our target price in Danaher as frustration is mounted after a messy quarter
Danaher's actions are under pressure on Wednesday, since the profit results of the fourth quarter of the Holding Club reached…
We are increasing our price target on GEHC, looking beyond a mixed quarter to next year's catalysts.
GE Healthcare reported a mixed quarter before Wednesday's opening bell. While revenue declined slightly, an improvement in earnings along with…
Danaher puts bioprocessing back into growth. We are raising our rating to buy
Danaher shares fell on Tuesday even though the life sciences company regained growth in its key bioprocessing business in the…
Abbott Labs shines with strong quarter and buyback announcement
Medical device maker Abbott Laboratories on Wednesday delivered better-than-expected quarterly results and raised its profit forecasts for the third consecutive…
GEHC gives reasons to look beyond China's temporary woes and stocks rise again
GE Healthcare reported a mixed second quarter on Wednesday morning, and shares initially dipped sharply. Shares then reversed higher as…
Eli Lilly (LLY) Says It Can Overcome the Problem of Too Much Demand for High Quality
Eli Lilly's improved guidance stole the show on Tuesday, offsetting mixed first-quarter results and sending shares up nearly 6%. The…